-
Posted by
Two Blokes Jun 9 -
Filed in
Stock
-
3 views
Poster Presentation Reviews the Hemopurifier \u00ae Affinity Resin's A bility to Bind Extracellular Vesicles in Long COVID Samples SAN DIEGO , June 9, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that an abstract has been accepted for poster presentation at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes being held at Eldorado Hotel & Spa, Santa Fe, NM, United States, August 10-13,2025 (https://www.keystonesymposia.org/conferences/conference-listing/meeting/program-highlights/F12026). Long COVID refers to persistent symptoms following acute SARs-CoV-2 infection (COVID-19).
